Biotoxtech
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
2 contract research organizations in our directory list both Carcinogenicity Studies and Dog among their capabilities, across 2 countries. 2 report GLP capability and 1 reports AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 2 CROs. Order rotates daily so no lab is permanently listed first.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.